Chandan targets 3,000 centres with no company capex in two years
Key highlights
- Chandan exceeded 685 franchise collection centres in September 2026, up from 264 on 30 June 2026.
- Chandan targets 1,000 franchise centres by the end of FY27 and 3,000 centres over the next two years.
- A franchisee invests approximately Rs 1 lakh in local set-up, while Chandan states it invests no capital in the outlet.
- Chandan retains at least 50% of each test's maximum retail price, while consumables represent approximately 15% to 21% of revenue.
powered by IRIS

Chandan Healthcare targets 3,000 franchise collection centres over the next two years after exceeding 685 centres in September 2026, with franchisees investing approximately Rs 1 lakh in local set-up and Chandan making no capital investment in those outlets. Samples collected at the centres are routed to Chandan laboratories for testing.
Know Chandan Healthcare inside out
Results, valuation, peers and who's buying, in one view.
What is Chandan's franchise expansion target?
Chandan's stated target is 3,000 franchise collection centres over the next two years, following an achieved network of more than 685 centres in September 2026. The roadmap also sets an intermediate company target of 1,000 centres by the end of FY27, or financial year 2027. These are company targets rather than reported future openings.
The plan is intended to extend last-mile pathology sample collection rather than replicate full-service diagnostic facilities. Chandan says patients increasingly prefer a collection point within three to four kilometres of home, while its own centres alone cannot provide that proximity. Each franchise is linked to a Chandan laboratory or Comprehensive Diagnostic Centre for processing.
How quickly has Chandan expanded its collection network?
Chandan increased its achieved franchise count from 235 on 31 March 2026 to 264 on 30 June 2026, then to more than 685 in September 2026. This contrasts a 29-centre increase during the June quarter with an increase of more than 421 centres between June and September.
The September network was in addition to 25 Comprehensive Diagnostic Centres, 19 Diagnostic Centres and 25 standalone laboratories. Franchise outlets are collection points only, while the wider Chandan network provides pathology, radiology and imaging, cardiology investigations, neurology studies, preventive health check-up packages and specialised molecular testing.
Chandan's roadmap relies on its “One District, One Lab” build-out, which it says is intended to give each franchise a nearby processing laboratory and shorter turnaround times. The stated operating model consolidates samples from collection points into district laboratories, raising laboratory utilisation without requiring Chandan to establish a full diagnostic centre in every neighbourhood.
How does Chandan's franchise model operate without company capex?
Chandan appoints a local operator, typically an experienced phlebotomist, as franchisee, and the franchisee invests approximately Rs 1 lakh in a computer, printer and premises fit-out. Chandan states that it invests no capital in the franchise outlet, and bears no franchise rent, salary, local marketing or referral cost.
After a patient is registered on Chandan's system, the franchise collects the sample and transports it to the nearest Chandan laboratory for testing. Chandan releases reports online directly to the patient, while the local outlet can print them when required. Radiology patients are referred to Chandan imaging centres rather than being served at collection outlets.
The franchisee also places a running advance of Rs 25,000 to Rs 1 lakh with Chandan against tests, replenishing that balance as it is drawn down. Registrations flow directly into Chandan's systems. Chandan says it does not appoint a franchise within three to five kilometres of a company centre, except at an approximate two-kilometre distance in metropolitan markets.
Got a follow-up? Ask IRIS
What are the economics of a Chandan franchise collection centre?
Chandan retains at least 50% of the maximum retail price of each test, with a higher share at lower franchise volumes. Consumables represent approximately 15% to 21% of revenue, while Chandan does not bear franchise rent, staff pay, local promotion or referral expense.
For franchisees, Chandan says it provides support towards monthly collections of Rs 1 lakh to Rs 2 lakh and targets earnings above Rs 50,000 a month. These are intended collection and earning levels in the disclosed model, not reported average outcomes for every outlet.
The model assigns laboratory testing and digital reporting to Chandan while assigning neighbourhood collection and local outlet investment to the franchisee. This division supports the 3,000-centre plan because new collection points can feed existing or district laboratories without a Chandan-funded premises fit-out, rent commitment or outlet payroll.
How will digital channels and laboratories support the rollout?
Chandan's online diagnostics business commenced during FY26 and scaled through FY27, with online registrations within a franchise catchment routed to that franchisee. The Chandan 24x7 application had more than 3 lakh users and added approximately 10,000 users each month, supporting online test bookings, health-check bookings, digital reports and call-centre support.
The digital route uses real-time sample tracking, automated cash-collection processes, temperature-controlled transport and monitored turnaround times. Home-collection bookings provide real-time slot confirmation, phlebotomist tracking and allocation to the nearest available phlebotomist, extending access beyond the 685-plus franchise collection centres.
Chandan also reports more than 40 lakh Chandan Family loyalty members, with approximately 25,000 new members added monthly. Its referral base exceeds 40,000 doctors. These channels may provide registrations to the processing network, but the presentation does not disclose franchise revenue or revenue per collection centre.
Conclusion
Chandan's disclosed franchise strategy combines a target of 3,000 centres over two years with an asset-light structure: franchisees fund approximately Rs 1 lakh of local infrastructure, Chandan retains at least 50% of each test's maximum retail price, and laboratories process the samples. The rise from 264 centres in June 2026 to more than 685 in September 2026 shows the expansion pace reported so far.
The next disclosed milestones are 1,000 centres by the end of FY27 and 3,000 over the following two years. Investors should watch whether Chandan adds outlets while maintaining its stated three-to-five-kilometre catchment discipline, builds nearby processing capacity through One District, One Lab, and routes digital and home-collection registrations into franchise-linked testing volumes.


